患有眼睑原发性黏液细胞癌的年轻人：36 个月的随访。

IF 1.2 4区医学 Q2 MEDICINE, GENERAL & INTERNAL Military Medicine Pub Date : 2024-11-05 DOI:10.1093/milmed/usad477

Sama S Alazawi, Vienna G Katana

{"title":"患有眼睑原发性黏液细胞癌的年轻人：36 个月的随访。","authors":"Sama S Alazawi, Vienna G Katana","doi":"10.1093/milmed/usad477","DOIUrl":null,"url":null,"abstract":"Primary cutaneous mucinous carcinoma (PCMC) is a malignant adnexal tumor that masquerades as a benign periocular lesion. We present a case of a 29-year-old male with an eyelid PCMC misdiagnosed as a chalazion. He underwent Mohs microscopic surgery for definitive treatment, with no recurrence at his 36 month follow up. Given the rarity and poorer prognosis in younger patients, a high index of suspicion is crucial for biopsying periocular lesions that fail conservative therapy.","PeriodicalId":18638,"journal":{"name":"Military Medicine","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Young Man With Primary Mucinous Cell Carcinoma of the Eyelid: 36 Month Follow Up.\",\"authors\":\"Sama S Alazawi, Vienna G Katana\",\"doi\":\"10.1093/milmed/usad477\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Primary cutaneous mucinous carcinoma (PCMC) is a malignant adnexal tumor that masquerades as a benign periocular lesion. We present a case of a 29-year-old male with an eyelid PCMC misdiagnosed as a chalazion. He underwent Mohs microscopic surgery for definitive treatment, with no recurrence at his 36 month follow up. Given the rarity and poorer prognosis in younger patients, a high index of suspicion is crucial for biopsying periocular lesions that fail conservative therapy.\",\"PeriodicalId\":18638,\"journal\":{\"name\":\"Military Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2024-11-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Military Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/milmed/usad477\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Military Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/milmed/usad477","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

摘要

原发性皮肤黏液癌（PCMC）是一种恶性附件肿瘤，可伪装成眼周良性病变。我们介绍了一例被误诊为霰粒肿的 29 岁男性眼睑原发性皮肤黏液癌病例。他接受了莫氏显微手术进行明确治疗，随访 36 个月未见复发。鉴于年轻患者的罕见性和较差的预后，在对保守治疗失败的眼周病变进行活检时，高度怀疑至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Young Man With Primary Mucinous Cell Carcinoma of the Eyelid: 36 Month Follow Up.

Primary cutaneous mucinous carcinoma (PCMC) is a malignant adnexal tumor that masquerades as a benign periocular lesion. We present a case of a 29-year-old male with an eyelid PCMC misdiagnosed as a chalazion. He underwent Mohs microscopic surgery for definitive treatment, with no recurrence at his 36 month follow up. Given the rarity and poorer prognosis in younger patients, a high index of suspicion is crucial for biopsying periocular lesions that fail conservative therapy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Military Medicine MEDICINE, GENERAL & INTERNAL-

CiteScore

2.20

自引率

8.30%

发文量

393

审稿时长

4-8 weeks

期刊介绍： Military Medicine is the official international journal of AMSUS. Articles published in the journal are peer-reviewed scientific papers, case reports, and editorials. The journal also publishes letters to the editor. The objective of the journal is to promote awareness of federal medicine by providing a forum for responsible discussion of common ideas and problems relevant to federal healthcare. Its mission is: To increase healthcare education by providing scientific and other information to its readers; to facilitate communication; and to offer a prestige publication for members’ writings.